Get started
Work

Abstract CT153: Pretreatment immunoscore and an inflamed tumor microenvironment (TME) are associated with efficacy in patients (Pts) with refractory large B cell lymphoma treated with axicabtagene ciloleucel (Axi-Cel) in ZUMA-1

Year: 2019
Type: conference-abstract
DOI: 10.1158/1538-7445.am2019-ct153
Authors: John M. Rossi, Jérôme Galon, Edmund Chang, Regis Perbost, Nathalie Scholler, Sarah Turcan, Corinne Danan, Frederick L. Locke, Sattva S. Neelapu, David B. Miklos, Caron A. Jacobson, Lazaros J. Lekakis, Yi Lin, Armin Ghobadi, Francesca Milletti, William Y. Go, Adrian Bot
Institutions: Inserm, Université Paris Descartes, Université Pierre-et-Marie-Curie, Moffitt Cancer Center, The University of Texas MD Anderson Cancer Center, Stanford Medicine, Stanford University, Dana-Farber Cancer Institute, University of Miami Health System, Sylvester Comprehensive Cancer Center, Mayo Clinic, Washington University in St. Louis
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: closed
OpenAlex ID: W2966674471
Cites:
Cited by: 7
Related to: 10